Nyxoah S.a.
Clinical trials sponsored by Nyxoah S.a., explained in plain language.
-
New implant offers hope for sleep apnea sufferers who Can't use CPAP
Disease control OngoingThis study tracks 110 adults with moderate to severe obstructive sleep apnea who have the Genio® device implanted. The device is designed to keep the airway open during sleep. Researchers are checking for serious side effects and measuring improvements in breathing and quality of…
Phase: NA • Sponsor: Nyxoah S.A. • Aim: Disease control
Last updated May 26, 2026 05:25 UTC
-
New implant could help sleep apnea sufferers ditch the CPAP mask
Disease control OngoingThis study tests a small implant that stimulates a nerve in the neck to keep the airway open during sleep. It is for adults with moderate-to-severe obstructive sleep apnea who cannot use a CPAP machine. The main goal is to see if the device safely reduces breathing pauses and imp…
Phase: NA • Sponsor: Nyxoah S.A. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New implant could help sleep apnea patients who Can't use CPAP
Disease control OngoingThis study tests a device called Genio® that stimulates a nerve in the neck to keep the airway open during sleep. It is for adults aged 22 to 75 with obstructive sleep apnea who have not been helped by CPAP and have complete collapse of the soft palate. The main goal is to see if…
Phase: NA • Sponsor: Nyxoah S.A. • Aim: Disease control
Last updated May 19, 2026 11:59 UTC